Xyosted 75 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FW95C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,436
Award facts
- Contract value 100% obligated
- $1,436.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,436.03 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Xyosted 75 mg/0.5 ml auto-injector units. The contract is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in supplying a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to deliver specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Xyosted is a testosterone replacement therapy product, reflecting the contractor's extensive portfolio of hormone treatments and specialized pharmaceutical commodities maintained under the comprehensive DLA framework.
Quick answers
Who was awarded contract SPE2DB25FW95C?
SPE2DB25FW95C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FW95C worth?
The government has obligated $1,436 on SPE2DB25FW95C.
Is contract SPE2DB25FW95C an order under another contract?
Yes. SPE2DB25FW95C is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FW95C competed?
The extent of competition for SPE2DB25FW95C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award